A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes

Abstract

The Pt^IV prodrug strategy has emerged as an excellent alternative to tackle the problems associated with conventional Pt^II drug therapy. However, there is a lack of tools to study how this new class of Pt^IV drugs are processed at the cellular level. Herein, we report the first ratiometric probe for cisplatin detection and use it to investigate Pt^IV anticancer complexes in biological systems. The probe was able to distinguish between cisplatin and its Pt^IV derivatives, allowing us to probe the intracellular reduction of Pt^IV prodrug complexes. The correlation between the amount of active Pt^II species available after intracellular reduction of Pt^IV complexes and their cytotoxicity and the role glutathione plays in the reduction of Pt^IV complexes were investigated.

Keywords: cisplatin; fluorescent probes; glutathione; platinum; prodrugs.